Loading...
Keywords
Last Name
Institution

Search Results (28)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Cytochrome P-450 CYP2C19Concept Why?
Cytochrome P-450 CYP2C19 InducersConcept Why?
Cytochrome P-450 CYP2C19 InhibitorsConcept Why?
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.Academic Article Why?
Lack of weight-based dose dependency and intraindividual variability of omeprazole for CYP2C19 phenotyping.Academic Article Why?
Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations.Academic Article Why?
Gaedigk, AndreaPerson Why?
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.Academic Article Why?
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.Academic Article Why?
Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect.Academic Article Why?
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".Academic Article Why?
The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.Academic Article Why?
Leeder, J. StevenPerson Why?
Interethnic differences of drug-metabolizing enzymes.Academic Article Why?
Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker.Academic Article Why?
Per Page    Page  of 2last Nextnext
Prev
Search Criteria
  • CYP2C19
Filter by Type